Binding Properties of β-Blockers at Recombinant β1-, β2-, and β3-Adrenoceptors

Abstract

The human heart contains at least four distinct beta-adrenoceptor subtypes, three of which have been cloned. However, the binding properties of beta-blockers to the different beta-adrenoceptor subpopulations are not yet thoroughly characterized. Human beta1-, beta2- and beta3-adrenoceptors were expressed in COS-7 cells and [125I]iodocyanopindolol saturation binding, and competition experiments with commonly used beta-blockers were performed in the respective membrane preparations. Atenolol and metoprolol were about fivefold selective for beta1- versus beta2- and beta3-adrenoceptors. Bisoprolol was approximately 15-fold selective for beta1- versus beta2- and approximately 31-fold selective for beta1- versus beta3-adrenoceptors. Carvedilol was nonselective for any beta-adrenoceptor subtype. We conclude that the beta1-selectivities of atenolol, metoprolol, and bisoprolol are lower in COS cell membranes compared with previous investigations performed in native membranes. All beta-blockers investigated bind to beta3-adrenoceptors. Differential binding properties to beta3-adrenoceptors might imply different responses as to body weight, cardiac contractility, heart rate, and growth regulation. This might imply differential indications for the drugs investigated.

Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model*

“…Second, based on its pharmacologic mechanism of action, carvedilol would be predicted to lower the risk for adverse cardiovascular events by decreasing heart rate and systemic blood pressure, which are commonly associated with MDMA intoxication (24). Third, carvedilol provides a markedly improved pharmacologic spectrum of action for the management of sympathomimetic toxicity compared with other nonselective ␤-blockers, such as propranolol and nadolol, which lack affinity for ␣ 1 -or ␤ 3 -AR (25), and therefore may enhance ␣ 1 -AR-mediated vasoconstriction and heat retention.…”

GW427353 (Solabegron), a Novel, Selective β3-Adrenergic Receptor Agonist, Evokes Bladder Relaxation and Increases Micturition Reflex Threshold in the Dog

“…Saturation binding experiments were performed as described previously (Schnabel et al, 2000), except a 50-l volume was used and incubation was for 30 min at 37°C. A range of final concentrations of […”

Clinical Impact of Bisoprolol Versus Carvedilol in Patients Undergoing Femoropopliteal Stenting

“…First, bisoprolol is the most β1-selective agent among the oral beta-blockers 17,18) , which allows it to be administered to patients with respiratory diseases. Bisoprolol also has only a mild negative effects on glucose metabolism.…”